Evaluation of autoantibody signatures in meningioma patients using human proteome arrays

Meningiomas are one of the most common tumors of the Central nervous system (CNS). This study aims to identify the autoantibody biomarkers in meningiomas using high-density human proteome arrays (~17,000 full-length recombinant human proteins). Screening of sera from 15 unaffected healthy individuals, 10 individuals with meningioma grade I and 5 with meningioma grade II was performed. This comprehensive proteomics based investigation revealed the dysregulation of 489 and 104 proteins in grades I and II of meningioma, respectively, along with the enrichment of several signalling pathways, which might play a crucial role in the manifestation of the disease. Autoantibody targets like IGHG4, CRYM, EFCAB2, STAT6, HDAC7A and CCNB1 were significantly dysregulated across both the grades. Further, we compared this to the tissue proteome and gene expression profile from GEO database. Previously reported upregulated proteins from meningioma tissue-based proteomics obtained from high-resolution mass spectrometry demonstrated an aggravated autoimmune response, emphasizing the clinical relevance of these targets. Some of these targets like SELENBP1 were tested for their presence in tumor tissue using immunoblotting. In the light of highly invasive diagnostic modalities employed to diagnose CNS tumors like meningioma, these autoantibody markers offer a minimally invasive diagnostic platform which could be pursued further for clinical translation.

[1]  Dejun Yang,et al.  Tumor protein D52-like 2 accelerates gastric cancer cell proliferation in vitro. , 2015, Cancer biotherapy & radiopharmaceuticals.

[2]  L. Dai,et al.  Evaluation of Diagnostic Value in Using a Panel of Multiple Tumor-Associated Antigens for Immunodiagnosis of Cancer , 2014, Journal of immunology research.

[3]  Andrew R. Hall,et al.  Evidence That Selenium Binding Protein 1 Is a Tumor Suppressor in Prostate Cancer , 2015, PloS one.

[4]  A. Dmoszyńska,et al.  Aberrant TIRAP and MyD88 expression in B-cell chronic lymphocytic leukemia. , 2013, Blood cells, molecules & diseases.

[5]  Gordon K Smyth,et al.  Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .

[6]  K. Baggerly,et al.  Global analysis of aberrant pre-mRNA splicing in glioblastoma using exon expression arrays , 2008, BMC Genomics.

[7]  Jeffrey E. Lee,et al.  Identification of DRG-1 As a Melanoma-Associated Antigen Recognized by CD4+ Th1 Cells , 2015, PloS one.

[8]  Sandipan Ray,et al.  Quantitative Proteomic Analysis of Meningiomas for the Identification of Surrogate Protein Markers , 2014, Scientific Reports.

[9]  K. Miura,et al.  The Drg-1 gene suppresses tumor metastasis in prostate cancer. , 2003, Cancer research.

[10]  J. Weickert,et al.  Novel immunogenic antigens increase classification accuracy in meningioma to 93.84% , 2011, International journal of cancer.

[11]  M. Kalamarides,et al.  New insights into meningioma: from genetics to trials , 2012, Current opinion in oncology.

[12]  G. Scita,et al.  The eps8 family of proteins links growth factor stimulation to actin reorganization generating functional redundancy in the Ras/Rac pathway. , 2003, Molecular biology of the cell.

[13]  M. Cattaneo,et al.  Silencing of Eps8 inhibits in vitro angiogenesis. , 2015, Life sciences.

[14]  Matko Bosnjak,et al.  REVIGO Summarizes and Visualizes Long Lists of Gene Ontology Terms , 2011, PloS one.

[15]  W. Couldwell,et al.  Incidental meningiomas. , 2011, Neurosurgical focus.

[16]  Xueya Wang,et al.  Tumor protein D52-like 2 contributes to proliferation of breast cancer cells. , 2015, Cancer biotherapy & radiopharmaceuticals.

[17]  Eckart Meese,et al.  A minimally invasive multiple marker approach allows highly efficient detection of meningioma tumors , 2006, BMC Bioinformatics.

[18]  M. Vidal,et al.  Mutations that disrupt PHOXB interaction with the neuronal calcium sensor HPCAL1 impede cellular differentiation in neuroblastoma , 2014, Oncogene.

[19]  M. Uppin,et al.  Assessment of expression of epidermal growth factor receptor and p53 in meningiomas. , 2014, Neurology India.

[20]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[21]  Davide Heller,et al.  STRING v10: protein–protein interaction networks, integrated over the tree of life , 2014, Nucleic Acids Res..

[22]  S. Mohan,et al.  Identification of Gender-Specific Candidate Genes that Influence Bone Microarchitecture in Chromosome 1 , 2012, Calcified Tissue International.

[23]  A. Órfão,et al.  Gene Expression Profiles of Meningiomas are Associated with Tumor Cytogenetics and Patient Outcome , 2009, Brain pathology.

[24]  Jef D. Boeke,et al.  Rapid Identification of Monospecific Monoclonal Antibodies Using a Human Proteome Microarray* , 2012, Molecular & Cellular Proteomics.

[25]  I. Azimi,et al.  A role for calcium in the regulation of ATP-binding cassette, sub-family C, member 3 (ABCC3) gene expression in a model of epidermal growth factor-mediated breast cancer epithelial-mesenchymal transition. , 2015, Biochemical and biophysical research communications.

[26]  B. G. Blijenberg,et al.  Screening and prostate-cancer mortality in a randomized European study. , 2009, The New England journal of medicine.

[27]  Christina Backes,et al.  Complex humoral immune response against a benign tumor: frequent antibody response against specific antigens as diagnostic targets. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Sanjeeva Srivastava,et al.  Multipronged quantitative proteomic analyses indicate modulation of various signal transduction pathways in human meningiomas , 2015, Proteomics.

[29]  E. Blalock,et al.  The metastasis suppressor NME1 regulates expression of genes linked to metastasis and patient outcome in melanoma and breast carcinoma. , 2014, Cancer genomics & proteomics.

[30]  P. Bracci,et al.  Assessment of autoantibodies to meningioma in a population-based study. , 2013, American journal of epidemiology.

[31]  Qing Zhu,et al.  Using immunoproteomics to identify tumor-associated antigens (TAAs) as biomarkers in cancer immunodiagnosis. , 2013, Autoimmunity reviews.

[32]  Lei Zhang,et al.  LIM protein JUB promotes epithelial–mesenchymal transition in colorectal cancer , 2014, Cancer science.

[33]  W. Nastainczyk,et al.  MGEA6 is tumor-specific overexpressed and frequently recognized by patient-serum antibodies , 2002, Oncogene.

[34]  Z. Hall.  Cancer , 1906, The Hospital.

[35]  M. Ziman,et al.  Autoantibody Production in Cancer--The Humoral Immune Response toward Autologous Antigens in Cancer Patients. , 2016, Autoimmunity reviews.

[36]  Eli Gilboa,et al.  The determinants of tumour immunogenicity , 2012, Nature Reviews Cancer.

[37]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[38]  B. Dean,et al.  SELENBP1 expression in the prefrontal cortex of subjects with schizophrenia , 2015, Translational Psychiatry.

[39]  D. Enki,et al.  Activation of multiple growth factor signalling pathways is frequent in meningiomas , 2016, Neuropathology : official journal of the Japanese Society of Neuropathology.

[40]  G. Reifenberger,et al.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.

[41]  Wancai Yang,et al.  Transcriptional Regulation and Biological Functions of Selenium-Binding Protein 1 in Colorectal Cancer In Vitro and in Nude Mouse Xenografts , 2009, PloS one.

[42]  A. Órfão,et al.  Genetic/molecular alterations of meningiomas and the signaling pathways targeted , 2015, Oncotarget.

[43]  Man Zhang,et al.  Discovery of potential bladder cancer biomarkers by comparative urine proteomics and analysis. , 2013, Clinical genitourinary cancer.

[44]  M. Preusser,et al.  Biology and clinical management challenges in meningioma. , 2015, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

[45]  Development and characterization of monoclonal antibodies against pancreatic cancer marker hippocalcin-like 1 protein. , 2014, Monoclonal antibodies in immunodiagnosis and immunotherapy.

[46]  J. Whitelegge,et al.  Proteomics Analysis of Brain Meningiomas in Pursuit of Novel Biomarkers of the Aggressive Behavior. , 2016, Journal of proteomics & bioinformatics.

[47]  J. Gohagan,et al.  Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. , 2011, JAMA.

[48]  Wancai Yang,et al.  Quantitative Proteomic Analysis Reveals That Anti-Cancer Effects of Selenium-Binding Protein 1 In Vivo Are Associated with Metabolic Pathways , 2015, PloS one.

[49]  M. Lindström,et al.  Role of ribosomal protein mutations in tumor development (Review) , 2016, International journal of oncology.

[50]  Ken Saito,et al.  Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression , 2004, Oncogene.

[51]  Jian-ying Zhang,et al.  Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors , 2010, Expert review of molecular diagnostics.

[52]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[53]  Stephen J Glatt,et al.  The utility of SELENBP1 gene expression as a biomarker for major psychotic disorders: Replication in schizophrenia and extension to bipolar disorder with psychosis , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[54]  J. Barnholtz-Sloan,et al.  CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. , 2013, Neuro-oncology.

[55]  L. Kenner,et al.  Identification of µ‐crystallin as an androgen‐regulated gene in human prostate cancer , 2009, The Prostate.

[56]  X. G. Li,et al.  Proteomic analysis of meningiomas , 2013, Acta Neurologica Belgica.

[57]  K. Takamatsu,et al.  Molecular cloning of a novel calcium-binding protein structurally related to hippocalcin from human brain and chromosomal mapping of its gene. , 1994, Biochimica et biophysica acta.